Country: Nigeria

The IRIS Academic Research Group was founded by some of the world’s leading researchers and academic institutions and launched in June 2021 at the inaugural Global Vaccine Confidence Summit as part of the UK government’s G7 Presidency.

Johnson & Johnson Global Public Health has created a series of unbranded research-based tools to equip vaccine confidence efforts in Africa.

This 2-page briefing provides an overview of the key trends and insights observed across the three waves of data collection that have been conducted as part…

Johnson & Johnson Global Public Health has worked with Fraym to create a series of geospatial mapping reports aimed at improving hyper-local understanding of vaccine hesitancy across sub-saharan Africa.

Project to support the development of guidance on interventions to improve vaccine uptake in LMICs, informed by an assessment of local barriers and drivers to adult vaccine uptake.

This blog for COVIDaction outlines the COVID-19 vaccination context in Nigeria and…

This report uses VCP data from 2015 – May 2021 to assess local barriers and drivers to adult vaccine uptake in Low – Middle Income Countries, with a view to supporting the development of targeted interventions and programs.

These reports visualise findings from surveys fielded across 14 African countries in January 2022.

In this study, we explore how intent to receive a COVID-19 vaccine evolved in Nigeria (both nationally and sub-nationally) between March 2021 (when the first vaccines were administered to healthcare workers) and October 2021.

Between October 31, 2020 and December 15, 2020, 26,759 individuals were surveyed across 32 countries via nationally representative survey designs.

Overview The Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine, in partnership with Premise, developed ASSURE – Assessing Signals and Supporting Resilience.

Dr. Abosede Lewu from Girlsaid Initiative describes his experience with HPV vaccine advocacy and…